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a b s t r a c t
The inﬂuence of CD25þCD4þ regulatory T cells (Treg) on acute and chronic viral infection of the central
nervous system (CNS) was examined using a glial tropic murine coronavirus. Treg in the CNS were
highest during initial T cell mediated virus control, decreased and then remained relatively stable during
persistence. Anti-CD25 treatment did not affect CNS recruitment of inﬂammatory cells. Viral control was
initially delayed; however, neither the kinetics of viral control nor viral persistence were affected. By
contrast, the absence of Treg during the acute phase resulted in increased demyelination during viral
persistence. These data suggest that CNS inﬂammation, progression of viral control and viral persistence
are relatively independent of CD25þCD4þ Treg. However, their absence during acute infection alters the
ability of the host to limit tissue damage.
& 2013 The Authors. Published by Elsevier Inc.
Introduction
Regulatory T cells (Treg) which express the Foxp3 transcription
factor, neuropilin 1 (Nrp-1) and the IL-2 receptor (CD25) comprise
10% of CD4þ T cells in the naïve animal and play an essential
role in regulating the immune response to infection, progression
of clinical disease and tissue damage (Langier et al., 2010;
Lourenco and La Cava, 2011; Rouse et al., 2006; Rowe et al.,
2012). During viral infection the host is challenged to mount an
effective anti-viral immune response while minimizing immune
mediated damage. Exuberant T cell effector function and tissue
damage are regulated by sustained natural Treg (nTreg), induction
of antigen speciﬁc Foxp3þ Treg (iTreg), secretion of the anti-
inﬂammatory cytokine IL-10 by both Foxp3þ and Foxp3 T cells,
as well as inhibitory ligand receptor interactions (Belkaid, 2007;
Curotto de Lafaille and Lafaille, 2009; Langier et al., 2010; Rowe
et al., 2012). Treg inﬂuence the immune response during a variety
of acute viral infections (Rouse et al., 2006; Rowe et al., 2012;
Zelinskyy et al., 2009) and are implicated in facilitating persistent
infections in both humans and mice (Dittmer et al., 2004; Rowe
et al., 2012; Xu et al., 2006). However, their suppressive role and
the mechanism(s) of suppression vary depending upon both the
pathogen and primary tissue infected. Following mucosal infection
by Herpes simplex virus type 2 (HSV-2) Treg facilitate recruitment
of virus effectors to the site of infection (Lund et al., 2008). They
also enhance the severity of murine hepatitis virus (MHV) induced
hepatitis due to their expression of the immunosuppressive
cytokine ﬁbrinogen-like protein 2 (Shalev et al., 2009). By contrast,
during acute respiratory syncytial virus (RSV) infection of the lung
or Herpes simplex virus type 1 (HSV-1) infection of the eye, Treg
limit cellular recruitment into the site of infection, diminishing
tissue destruction (Lee et al., 2010; Suvas et al., 2004). These
ﬁndings suggest that Treg play an important role in regulating
immunopathology associated with viral infection; however, this
anti-inﬂammatory regulation may also reduce anti-viral activity,
leading to delayed clearance and/or viral persistence.
The balance between an effective immune response, limited tissue
damage, and establishment of viral persistence is especially critical in
the central nervous system (CNS), due to its limited regenerative
capacity. Theiler's murine encephalomyelitis virus (TMEV) infection
produces an acute encephalitis in mouse strains either susceptible or
resistant to chronic CNS infection. Depletion and/or functional inacti-
vation of CD25þ Treg did not affect CNS inﬂammation or TMEV
replication in mice resistant to chronic infection (Richards et al., 2011).
The identical depletion strategy resulted in both enhanced inﬂamma-
tion and control of TMEV replication in the CNS of mice susceptible to
chronic infection (Richards et al., 2011). By contrast, Treg depletion
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prior to acute infection with a neuronotropic MHV, which also
produces chronic demyelination, did not alter CNS inﬂammation or
virus speciﬁc T cell responses (Cervantes-Barragan et al., 2012).
Following CNS infection with an MHV variant containing a mutation
in the immunodominant CD4þ T cell epitope which ameliorates
disease, anti-CD25 mediated Treg depletion increased both morbidity
and mortality (Anghelina et al., 2009). A beneﬁcial role of Treg was
also supported by adoptive transfer of nTreg at a time when CNS
infection by a sub-lethal, glial tropic JHM strain of MHV (JHMV) was
already established. The increased Treg ameliorated clinical disease
and immunopathology without altering viral clearance (Trandem
et al., 2010). Nevertheless, the role of CD25þ Treg in the pathogenesis
of acute JHMV encephalomyelitis and progression to persistent CNS
infection is unclear. To better deﬁne the role of CD25þ Treg early
during JHMV induced encephalomyelitis and potential consequences
on the chronic infection associated with sustained demyelination, the
present study examined depletion/functional inactivation of CD25þ
cells in wild type (WT) and syngeneic IL-10 reporter mice. The Treg
population, composed of both Nrp1hi and Nrp1low Treg, peaked in the
CNS during acute infection, declined as virus was controlled, and was
retained in the CNS during viral persistence. The absence of
CD25þCD4þ T cells did not inﬂuence the composition or extent of
the CNS inﬂammatory cells, including virus-speciﬁc CD8þ T cells.
However, CD25 depletion transiently impaired infectious virus control
in the absence of detectable differences in ex vivo cytolytic effector
function. The transient delay in virus control correlated with increased
tissue damage although viral persistence within the CNS was not
altered. These data support the concept that the regulation of the
immune response within the CNS by CD25þ T cells during JHMV
infection is conﬁned to a temporally narrow window during the
initiation and effector phase of the acute inﬂammatory response.
Results
Kinetics of CD25þ Nrp-1hi nTreg and Nrp-1low iTreg accumulation
in the CNS
Prior to initiating anti-CD25monoclonal antibody (mAb) treatment
the kinetics and relative composition of CD25þ and Foxp3þCD4þ
T cells recruited into the CNS were assessed following JHMV infection.
CNS accumulation of CD25þ and Foxp3þCD4þ Tcells followed similar
patterns throughout infection (Fig. 1A). Total numbers of both
CD25þCD4þ and Foxp3þ T cells peaked at day 7 post infection (p.i.)
comprising 20% of total CD4þ T cells (Fig. 1). These populations
declined rapidly by day 10 p.i. and stabilized thereafter (Fig. 1B and C).
Importantly, 475% of CD25þ cells expressed Foxp3þ at day 7 p.i.
indicating a minority of 25% non Treg CD4þ effector cells expressed
CD25 (Fig. 1A and D). These data show that the vast majority of the
Foxp3þ population expressed CD25 (Fig. 1A and D) and this propor-
tion remained stable at 75–80% throughout the infection (Fig. 1A
and D).
To distinguish a phenotypic transition of Treg populations,
possibly accompanied by differential expression of CD25, nTregs
were identiﬁed based on high Nrp-1 expression (Weiss et al.,
2012; Yadav et al., 2012). At day 7 p.i., Nrp-1hi nTreg represented
the majority (75%) of Foxp3þ Treg within the CNS (Fig. 2A and
B). At day 10 p.i., the frequency of Nrp-1hi nTreg declined to 50%
and remained stable at all subsequent time points, resulting in an
equal proportion of Nrp-1hi and Nrp-1low Treg (Fig. 2A and B).
Similar to the total Foxp3þ population (Fig. 1D), CD25 expression
remained stable at 75% on both Nrp-1hi (Fig. 2C) and Nrp-1low
Treg during the course of infection (Fig. 2C and D). These data
predicted that the majority of CD25þFoxp3þ Treg are susceptible
to anti-CD25 treatment. Moreover, CD25 treatment at early times
during infection was anticipated to primarily target prevailing
Nrp-1hi Treg and only a minor population of CD25þ effector T cells.
Early CD25þ T cell depletion does not alter morbidity or
inﬂammation
The role of CD25þ Treg in JHMV induced sub-lethal encepha-
lomyelitis and viral persistence was thus examined by infection of
mice treated with anti-CD25 mAb at day -3, 0, and þ3 relative to
infection. JHMV induces clinical symptoms associated with ence-
phalitis which transitions to predominantly hind limb paralysis.
Severity of clinical symptoms reﬂects both viral load and the anti-
viral immune response (Bergmann et al., 2006; Kapil et al., 2009;
Weiss and Leibowitz, 2011). Anti-CD25 treatment did not alter
disease onset, severity or the progression of clinical symptoms
Fig. 1. Recruitment of CD25þ Treg into the CNS. CD25þFoxp3þCD4þ T cells in the CNS of infected mice analyzed by ﬂow cytometry. (A) Representative density plots of
Foxp3 and CD25 expression, gated on CD4þ T cells. Numbers represent percentages of each population. Bar graphs depict total CD25þ (B) and total Foxp3þ CD4þ T cells
(C) recruited into the infected CNS. (D) Frequency of CD25þ within CD4þ Foxp3þ T cells. Data represent mean 7SEM of 6–9 individual mice per time point from at least
2 separate experiments.
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(Fig. 3A). These data contrast with the reduced morbidity
mediated by adoptive transfer of nTreg during JHMV infection
(Trandem et al., 2010). Therefore we assured the efﬁcacy of anti-
CD25 treatment. Anti-CD25 mAb eliminated essentially all CD25þ
T cells from the cervical lymph nodes (CLN) at least until day 14 p.
i.; a small percentage of CD4þCD25þ T cells, representing 15% of
control levels, emerged by day 21 p.i. (data not shown). Flow
cytometric analysis of CD4þ T cells recruited into the CNS
indicated the anti-CD25 treatment was also effective at the site
of infection at least until day 14 p.i. (Fig. 3B and C). At day 21 p.i.,
the frequency of CD25þ CD4þ cells within the CNS of the anti-
CD25 treated group, returned to control levels, suggesting accu-
mulation of CD25þCD4þ T cells from the reemerging peripheral
pool. Neither total numbers of CD45hi inﬂammatory cells nor
CD11bþ macrophages recruited into the CNS were altered in the
anti-CD25 treated group compared to controls (Fig. 4A and B),
consistent with the similarity in clinical disease. Although CD25þ
T cells comprise up to 30% of CD4þ T cells in the CNS at day 7 p.i.
(Figs. 1A and 3C), total CD4þ T cells in the CNS were unaltered at
all times p.i. comparing anti-CD25 treated and control groups
(Fig. 4C). These data suggest the possible enrichment of CD4
effector T cells at the site of infection. These data also demonstrate
efﬁcient and sustained depletion/functional inactivation of CD25þ
T cells from both the periphery and CNS until day 14 p.i, spanning
the time frame of maximal T cell activation and CNS accumulation
(Bergmann et al., 2006; Phares et al., 2010). Moreover, their
absence did not alter either a clinical component of JHMV-
induced encephalitis or the cellular CNS inﬂammation.
Early CD25þ T cell depletion does not alter viral control or
T cell effector function
CD25þ T cell mediated regulation of anti-viral T cell activity
was examined by determining viral loads in the CNS (Fig. 5A).
Virus replication was not inﬂuenced by the absence of CD25þ T
cells at days 3 and 5 p.i., conﬁrming the absence of defects in
innate immunity critical for the early control of JHMV spread
(Ireland et al., 2008). However, at day 7 p.i. when anti-viral T cell
activity is maximal (Bergmann et al., 2006; Phares et al., 2010).
CNS viral replication was increased in anti-CD25 compared to
control mAb treated mice (Fig. 5A). A marginal, but not statistically
signiﬁcant, increase in infectious virus was sustained to day 10 p.i.
(Fig. 5A). Nevertheless, impaired virus control was transient, as no
differences were detected at day 14 p.i. and infectious virus was
undetectable in the CNS of either group at day 21 p.i. (Fig. 5A).
Consistent with delayed, but eventually effective viral control, no
clinical evidence of viral recrudescence was found in CD25
depleted mice.
T cell mediated cytolytic activity and IFN-γ are the primary
immune effectors controlling JHMV replication within the CNS
(Bergmann et al., 2006) and Treg depletion enhances CD8þ T cell
number and activity (Dietze et al., 2011; Haeryfar et al., 2005).
Comparison of anti-CD25 treated and control mice indicated no
affect on CNS IFN-γ mRNA levels or frequencies of virus-speciﬁc T
cells secreting IFN-γ (data not shown). The limited control of viral
replication at day 7 p.i. in the absence of CD25þ T cells (Fig. 5A)
did not coincide with impaired CNS recruitment of total CD8þ
T cells (Fig. 5B). Although recruitment of CD8þ T cells into the CNS
was increased at days 10 and 14 p.i., these increases did not reach
statistical signiﬁcance. Similarly, the apparent increase in virus
speciﬁc CD8þ T cells at days 10 and 14 p.i. also did not reach
statistical signiﬁcance (Fig. 5C). During inﬂuenza virus infection of
the lung, highly cytolytic IL-10 producing CD8þ T cells are
dependent upon CD4þ T cells (Sun et al., 2011), suggesting a
possible inﬂuence of CD4þCD25þ T cells on CD8þ T cell function
during JHMV. Furthermore, an IL-10þCD8þ T cell population
constituting 25% of virus-speciﬁc CD8þ T cells resides within
the JHMV infected CNS at day 7 p.i. (Puntambekar et al., 2011),
comprising CD8þ T cells with high cytolytic potential (Trandem
et al., 2011a). Anti-CD25 treated and control IL-10 reporter mice
were therefore infected to examine the possibility of diminished
IL-10þ effector CD8þ T cells. Similar to WT mice, anti-CD25 mAb
treatment was effective at eliminating CD25þCD4þ T cells from
the CNS of infected IL-10 reporter mice until at least day 14 p.i
(data not shown). Anti-CD25 treatment reduced the frequency of
IL-10þCD4þ T cells by 30% at day 7 p.i.; however, the population
returned to WT levels by day 10 p.i (data not shown). In contrast to
the CD4þ T cell population, virus speciﬁc CD8þ IL-10þ were
slightly reduced at both days 7 and 10 p.i.; however, these
decreases also did not reach statistical signiﬁcance. CNS derived
mononuclear cells from infected anti-CD25 and control mAb
treated mice were also tested for direct ex vivo cytolytic activity
Fig. 2. Kinetics of Nrp-1hi and Nrp-1low CD4þFoxp3þ in the infected CNS. Neuropilin-1 (Nrp-1) expression on CD4þFoxp3þ T cells within the infected CNS analyzed by ﬂow
cytometry. (A) Representative density plots of Nrp1 expression. Gated on CNS derived CD45hiFoxp3þCD4þ T cells. Numbers represent percentages of each population. Bar
graphs depicting frequencies of Nrp-1hi cells in CD4þFoxp3þ T cells (B), CD25þ cells in Nrp-1hiFoxp3þCD4þ T cells (C) and CD25þ in Nrp-1lowFoxp3þCD4þ T cells (D). Data
represent mean 7SEM of 3–6 individual mice per time point.
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at day 7 p.i. Although virus replication was increased at day 7 p.i.
in the anti-CD25 treated group (Fig. 5A), cytolytic activity by CNS
derived CD8þ T cells was not altered by anti-CD25 treatment
(Fig. 5E). Furthermore, cytolytic activity in both anti-CD25 and
control mAb treated groups decreased at day 10 p.i. (data not
shown), consistent with previous results (Bergmann et al., 1999).
Thus the transiently increased viral load in the absence of
CD25þCD4þ T cells could not be correlated with either reduced
IFN-γ, virus-speciﬁc CD8þ T cell recruitment or cytolytic activity.
Transiently decreased anti-viral activity may thus be due to
insufﬁcient help provided by CD25þCD4þ T cells (Phares et al.,
2012) or induction of inhibitory molecules (Phares et al., 2009),
neither of which would be directly reﬂected by in vitro analysis.
Early CD25þ T cell depletion does not alter persistence but limits
demyelination
A number of chronic viral infections are associated with
CD25þCD4þ Treg (Belkaid, 2007; Rowe et al., 2012). However,
no clinical or virological evidence for viral recrudescence was
found in the anti-CD25 treated group (Figs. 3A and 5A), similar to
control mice. Therefore, the ability of CD25þ T cells to inﬂuence
Fig. 3. Encephalomyelitis is independent of CD25þCD4þ T cells. WT mice received 250 μg of anti-CD25 or isotype control mAb i.p. at days 3, 0 and 3 relative to JHMV
infection. (A) Clinical symptoms of anti-CD25 treated and control mice. Data are mean7SEM and represent 3 combined experiments comprising 53 mice per group. (B) Flow
cytometric analysis of CD25 expression on CD45hiCD4þ T cells isolated from the infected CNS. Circled populations represent percentages of CD25þ T cells within CD4þ T
cells. Representative data from 2 separate experiments. (C) Bar graph representing the frequency of CD25þ T cells within the CNS. Data are mean7SD and represent a
combination of 2–7 experiments with 3 mice per time point in each experiment.
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viral persistencewas examined by PCR due to the absence of infectious
virus during JHMV persistence (Bergmann et al., 2006; Phares et al.,
2010). As expected based on the limited ability of anti-CD25 treated
mice to control viral load at day 7 p.i., expression of the mRNA
encoding the viral nucleocapsid (N) protein was increased in the
brains of anti-CD25 treated mice compared to controls (data not
shown). At subsequent times p.i., however, viral mRNA expressionwas
equivalent in the spinal cords of both groups (Fig. 6A), the predomi-
nant site of JHMV persistence (Bergmann et al., 2006; Marten et al.,
2000). These results indicate that diminished viral control during the
acute phase of coronavirus mediated encephalomyelitis in the absence
of CD25þCD4þ T cells did not facilitate viral persistence.
The transient decrease in control of CNS viral replication,
decreased demyelination mediated by nTreg adoptive transfer in
Fig. 4. Recruitment of CNS inﬂammatory cells in the absence of CD25þ T cells. CNS inﬂammatory cells in infected anti-CD25 or control treated mice. Bar graphs depict total
CD45hi inﬂammatory cells (A), CD11bþCD45hi macrophages (B) and CD4þ T cells (C) per brain of infected mice. Data are mean7SD of 2–3 combined experiments with
pooled brains from 3 mice per time point in each experiment.
Fig. 5. Viral control is independent of CD25þCD4þ T cells. (A) Infectious virus within the CNS of individual anti-CD25 and control mAb treated mice. Data represent
2 combined experiments. Line represents the limit of detection. Statistical differences determined by two tailed unpaired t test. *p¼o0.05. Bar graphs depict total CD8þ T
cells (B) and virus speciﬁc CD8þ T cells (C) per brain. (D) Frequencies of IL-10þtetramerþ cells within in CNS CD8þ T cells. Data are mean7SD and represent 2–4 combined
experiments with 3 mice per time point in each experiment. (E) Virus speciﬁc cytolytic activity of CNS derived mononuclear cells from mice with or without anti-CD25
treatment. Data are expressed as percentage of speciﬁc lysis (mean7SEM) of S510 peptide coated targets at various effector: target (E:T) ratios, adjusted for the frequency of
tetramerþCD8þ T cells. Data are representative of 2 separate experiments with pooled cells from 6–7 mice per group.
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a similar model of JHMV infection (Trandem et al., 2010) and the
delayed onset of demyelination in anti-CD25 treated TMEV
infected mice (Richards et al., 2011) suggested that CD25þCD4þ
T cells might inﬂuence JHMV induced tissue damage. Therefore,
spinal cords from anti-CD25 treated and control mice were
compared for inﬂammation, the extent and distribution of viral
antigen, as well as demyelination at day 14 p.i. when viral mRNA
levels were equivalent (Fig. 6A). No differences in the extent or
distribution of inﬂammatory cells were detected comparing the
two groups (Fig. 6B). Similar inﬂammation is consistent with the
overall recruitment of both inﬂammatory cells (Fig. 4A) and their
composition (Figs. 4 and 5). Although few infected cells were
found in either group (Fig. 6B), consistent with low levels of
infectious virus (Fig. 5A), the predominant cell type infected
exhibited the morphology and anatomical location of oligoden-
droglia and was similar in both groups (Fig. 6B). These data
suggested that anti-CD25 treatment did not alter viral tropism.
To determine if the transiently increased viral load during the
acute phase of infection prolonged or worsened tissue damage,
demyelination was quantiﬁed in both groups at different times p.i.
No difference in demyelination was apparent at day 7 p.i. (Fig. 6C).
However, the extent of demyelination was increased in the spinal
cords of the CD25 deﬁcient mice at days 14 and 21 p.i (Fig. 6B and
C). These data support the notion that the early events of viral
induced tissue damage within the CNS are not regulated by
CD25þCD4þ Treg cells. However, these data support the concept
notion that the subsequent presence of Treg in the damaged CNS is
not sufﬁcient to stem demyelination initiated during the early
phase of virus replication.
Discussion
During viral infections Treg can suppress T cell activity at
multiple levels. They can directly limit T cell priming in the
draining lymph nodes and trafﬁcking to the effector site (Lee
et al., 2010; Suvas et al., 2004) where they can further dampen
T cell effector function to prevent bystander damage. Indeed,
recent evidence suggests that suppression is more important at
the site of infection (Ding et al., 2012). However, suppressing an
anti-viral response may also allow virus dissemination to cells
critical for maintaining homeostasis and/or facilitate viral persis-
tence (Belkaid, 2007; Rouse et al., 2006; Rowe et al., 2012). In this
regard the CNS presents an especially challenging site to control
infection due to the limited capacity for regeneration of specia-
lized cells. JHMV induces an acute encephalomyelitis characterized
by the recruitment of a variety of innate and adaptive immune
effectors into the CNS (Bergmann et al., 2006), including Treg
(Anghelina et al.; 2009, Puntambekar et al., 2011). Although
reduced tissue damage following adoptive transfer of nTreg at
the peak of acute JHMV encephalitis (Trandem et al., 2010)
implicated a local protective role, protection was not associated
Fig. 6. CD25þ T cell inﬂuence on JHMV persistence and pathology. (A) Relative transcript levels of viral N protein mRNA in spinal cords during persistence. Data expressed as
mean7SEM relative to GAPDH mRNA with 3 individuals per time point. Representative of 2 experiments with the same trend in each experiment. (B) Spinal cords from
JHMV infected WT mice treated with either anti-CD25 or anti-βGal mAb at day 14 p.i. Inﬂammatory cells identiﬁed with H&E (top panel), viral infected cells identiﬁed with
anti-N mAb J3.3 (middle panel) and demyelination assessed with LFB (bottom panel). Representative sections from 2 experiments with 3–5 mice per experiment.
Bar¼200 μm. Insert bars¼50 μm. (C) Percentage demyelination in spinal cord white matter in individual mice calculated by analysis of transverse sections at 6 separate
levels per mouse expressed as mean7SEM with 3–5 mice per time point. Representative of 2 separate experiments with the same trends. Statistical differences determined
by two tailed unpaired t test. *p¼o0.05.
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with either Treg recruitment into the CNS or decreased virus
replication (Trandem et al., 2010). These results suggested that
after infection is established the primary site of Treg function may
be the CLN. Our data demonstrate that the high frequency of Treg
recruited into the CNS during the peak of acute inﬂammation
declines as virus replication is controlled. Consistent with previous
data (Puntambekar et al., 2011) Treg are nevertheless retained
within the CNS during persistence. Moreover, the majority of Treg
expressed a Npr-1hi phenotype during peak CNS inﬂammation,
consistent with their previous designation as nTreg based on
expression of the helios transcription factor (Zhao et al., 2011).
The Treg population within the CNS declined dramatically by day
10 p.i. as virus replication was controlled. However, the Nrp-1low
Treg population increased to a stable 50% of total Treg as virus
replication was controlled and similar proportions of Nrp-1hi and
Nrp-1low Treg were retained in the CNS.
To determine if Treg inﬂuenced acute JHMV infection and
subsequently demyelination, mice were treated with anti-CD25
mAb prior to infection. This well established methodology has
been used to minimize the inﬂuence of Treg on viral pathogenesis
in both the CNS and at other anatomical sites. Inhibition of IL-2-IL/
IL-2R interactions may explain the limited inﬂammation in some
viral infections (Fulton et al., 2010; Ruckwardt et al., 2009), but
it has no effect on inﬂammation in others (Betts et al., 2011). In
addition, anti-CD25 treatment increases CD8þ T cells responses
under some, but not all circumstances (Betts et al., 2011; Dietze
et al., 2011; Fulton et al., 2010; Haeryfar et al., 2005; Ruckwardt
et al., 2009). Both CD25þCD4þ T cells and CD4þ IL-10þ T cells are
rapidly recruited into the JHMV infected CNS (Anghelina et al.,
2009; Puntambekar et al., 2011). However, both virus control and
inﬂammation are Treg independent following infection with a
related MHV (Cervantes-Barragan et al., 2012). Therefore, it was
not surprising that anti-CD25 treatment did not alter recruitment
of inﬂammatory cells into the CNS. Limited Treg mediated sup-
pression within the CNS is also consistent with an adverse
environment established during CNS inﬂammation (Korn et al.,
2007; Tang et al., 2008). Indeed, induction of IL-12 or IL-6 within
the CNS during JHMV infection (Kapil et al., 2009) may contri-
bute to limiting suppressive activity (Longhi et al., 2008;
Zhao et al., 2012). Furthermore a variety of inhibitory molecules,
i.e. Programmed death-1 ligand (PD-L1), as well as the anti-
inﬂammatory cytokine IL-10 inﬂuence JHMV pathogenesis
(Phares et al., 2010; Trandem et al., 2011b) potentially exhibiting
more potent regional effects than Treg. For example, JHMV infec-
tion of IL-10 deﬁcient mice demonstrated accelerated viral clear-
ance, yet dramatically enhanced tissue destruction (Trandem et al.,
2011a). During JHMV infection IL-10 secretion within the CNS
is limited to the T cell compartment with CD25þ IL-10þCD4þ
T cells, characteristic of nTreg, rapidly recruited into the CNS
(Puntambekar et al., 2011). The absence of a suppressive effect
suggested by anti-CD25 treatment may reside in the rapid repla-
cement of this population by CD25- IL-10þ CD4þ T cells
(Puntambekar et al., 2011), or the loss of CD25 expression.
Although the precise phenotype of the CD25-IL-10þCD4þ T cell
population is unclear, it is possible it comprises virus-speciﬁc
Foxp3þ Treg (Zhao et al., 2012) or virus-speciﬁc IL-10þ Foxp3-
cells regulated by IL-27 (Wojno and Hunter, 2012). Interestingly,
5% of Treg inﬁltrating the CNS during JHMV infection are virus-
speciﬁc (Zhao et al., 2011). As CD25 expression was not assessed
on this population, our data cannot exclude that enrichment of
this population in the CD25-Foxp3þ subset may contribute to
JHMV pathogenesis.
Control of CNS virus replication was partially inhibited at the
peak of replication, suggesting that CD25þCD4þ T cells enhanced
the initial phase of adaptive immunity. Although anti-CD25 treat-
ment did not alter numbers of inﬂammatory cells recruited into
the CNS or the proportions of anti-viral effectors, we cannot rule
out a transient CD25 dependent CD4þ helper T cell effect (Phares
et al., 2012), independent of the Treg population. This is supported
by increased mortality, despite similar JHMV clearance, in trans-
genic mice lacking both IL-27 and IL-35 (Tirotta et al., 2013)
suggesting that neither of these Treg associated cytokines regu-
lates viral clearance. One possibility to account for the limited
clearance of infectious virus in the absence of CD25þCD4þ T cells
is inhibition of CTL activity in vivo via the inhibitory ligand PD-L1
on CNS targets (Phares et al., 2009) which is not apparent in a
direct ex vivo assay. Although PD-L1 mRNA expression was slightly
increased in the CNS of the CD25þCD4þ T cell depleted mice
relative to controls (data not shown), the difference did not reach
statistical signiﬁcance. Together, these data indicate that Treg exert
minimal effects on anti-viral functions during acute JHMV induced
encephalomyelitis, similar to their inability to alter TMEV induced
encephalitis in resistant mice (Richards et al., 2011). Consistent
with functional anti-viral effectors, treatment with anti-CD25 did
not enhance or diminish viral persistence. These data contrast
with data from a number of both human and viral infections
suggesting that CD25þCD4þ Treg facilitate chronic viral infection
(Belkaid, 2007; Rouse et al., 2006; Rowe et al., 2012). Although
CD25þCD4þ T cells are rapidly recruited to the site of infection,
depletion and/or functional inactivation demonstrates the effect
on the inﬂammatory response within the CNS is transient, appear-
ing to decrease the initial set point for control of virus replication
without inﬂuencing viral persistence.
Transfer of Treg into mice with an established JHMV infection
limited demyelination, consistent with the concept that demyeli-
nation is mediated by adaptive immunity (Pewe and Perlman,
2002; Savarin et al., 2008). However, infection of mice treated with
anti-CD25 did not alter the extent of tissue damage during the
acute phase of infection. These data indicate that in contrast to
infection of the eye and mucosal sites (Lund et al., 2008; Suvas
et al., 2004), Treg do not constitute a primary mechanism of
damage control in the CNS during the period of maximal T cell
effector function. By contrast, the extent of demyelination
increased during viral persistence, even after CD25þ T cells were
re-established within the CNS. Thus despite the minimal inﬂuence
of CD25þCD4þ Treg on JHMV viral load and persistence, these
minimal alterations were sufﬁcient to inﬂuence the extent of
tissue damage. Nevertheless, less extensive tissue damage com-
pared to that found in the total absence of IL-10 (Trandem et al.,
2011a), suggests that in addition to Treg, other IL-10 secreting
regulatory populations contribute to limiting demyelination
following JHMV infection. Overall these results support the notion
that the presence of Treg in the CNS during persistence and
demyelination is linked to the control of acute viral load and the
resulting viral induced tissue damage.
Materials and methods
Mice and virus
C57BL/6 mice (WT) were purchased from the National Cancer
Institute (Frederick, MD). IL-10-GFP and Foxp3-GFP reporter mice
on the C57BL/6 background (Madan et al., 2009; Korn et al., 2007)
were bred locally under pathogen-free conditions. Female and
male mice at 6 weeks of age were infected intracranially (i.c.) with
1000 PFU of the sub-lethal glial tropic mAb-selected J2.2v-1
variant of JHMV (Fleming et al., 1986). Mice were scored daily
following infection for clinical signs as follows: 0, healthy; 1,
hunched back; 2, partial hind limb paralysis or reduced ability to
regain an upright position; 3, complete hind limb paralysis; 4,
moribund or dead (Fleming et al., 1986). All procedures were
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conducted in accordance with animal protocols approved by the
Institutional Animal Care and Use Committee of the Cleveland Clinic
Foundation. To deplete or functionally inactivate CD25þ T cells mice
received 3 intraperitoneal (i.p.) injections of 250 μg of anti-CD25 mAb
(clone PC61, rat IgG1) obtained from BioXCell (West Lebanon, NH) on
days -3, 0 and 3 relative to infection. Controls received 250 μg of an
irrelevant rat IgG1 mAb (clone GL113, anti-β-galactosidase), originally
obtained from Dr. R. Coffman (DNAX Corporation, Palo Alto, CA) and
prepared as described (Phares et al., 2012) on days -3, 0 and 3 relative
to infection.
Tissue processing and virus titration
Brains were homogenized in Dulbecco's PBS using ice cold
Tenbroeck tissue homogenizers (Wheaton Science Products,
Millville, NJ). After centrifugation at 450g for 7 min at 4 1C super-
natants were stored at 80 1C. Cell pellets were suspended in
RPMI medium containing 25 mM HEPES, pH 7.2 and used for the
analysis of CNS inﬂammation as described below. Brain derived
supernatants were used to determine virus titers by plaque assay
on monolayers of the continuous Delayed Brain Tumor (DBT)
astrocytoma cell line as described (Fleming et al., 1986; Kapil
et al., 2009; Phares et al., 2012)
Isolation of CNS cells
CNS derived cell pellets resuspended in RPMI medium contain-
ing 25mM HEPES (pH 7.2) were adjusted to 30% Percoll (Pharmacia,
Piscataway, NJ). Cells were separated from myelin debris by centrifu-
gation at 850g for 30 min at 4 1C onto a 70% Percoll cushion. Cells from
the 30%/70% interphase were collected, washed and analyzed by ﬂow
cytometry or for cytolytic activity. Single cell suspensions from CLN
were obtained as described (Bergmann et al., 1999; Kapil et al., 2009;
Phares et al., 2012).
Flow cytometric analysis
Cells were incubated at 4 1C with 1% mouse serum and 1% rat
anti-mouse CD16/CD32 mAb to prevent non-speciﬁc staining.
Surface marker expression was examined using mAb purchased
from BD Biosciences (San Diego, CA) unless otherwise noted.
Staining used ﬂuorescein isothiocyanate (FITC), phycoerythrin
(PE), Peridinin chlorophyll protein (PerCP) and allophycocyanin
(APC)–conjugated mAb speciﬁc for: CD45 (30-F11), CD4 (L3T4),
CD8 (53-6.7), F4/80 (Serotec, Raleigh, NC), MHC Class II (2G9),
CD25 (PC61), CD62L (Mel-14), CD44 (IM7), CD69 (H1-2F3) and
Npr-1 (R&D Systems, Minneapolis, MN). Virus speciﬁc CD8þ T cells
were identiﬁed using DbS510 MHC Class I tetramers (Bergmann
et al., 1999; Beckman Coulter, Fullerton, CA). Cells from IL-10-GFP
and Foxp3-GFP reporter mice were analyzed without ﬁxation and
GFP expression identiﬁed in the FL1/FITC channel as previously
described (Puntambekar et al., 2011). Cells were acquired on a
FACSCalibur or FACS Aria ﬂow cytometer (BD Biosciences), and the
data analyzed by FlowJo 7.6 software (Tree Star Inc., Ashland, OR).
Cytotoxic T lymphocyte assay
Speciﬁc lysis was determined using EL4 (H-2b) targets pulsed
with 1 μM of S510 peptide encoding the H-2Db restricted immu-
nodominant epitope in serum free RPMI medium for 1 h at 37 1C.
After washes, S510 coated cells were labeled with high (2.5 μM)
and control cells (no peptide) with low (0.125 μM) carboxyﬂuor-
escein succinimidyl ester (CFSE; Molecular Probes, Eugene OR),
respectively. High and low CSFE labeled targets (5103) were
plated into 96 well plates in a volume of 100 ml. CNS derived cells
were added in a volume of 100 ml at various effector: target (E:T)
ratios based on the frequency of virus speciﬁc CD8þ T cells
identiﬁed with DbS510 tetramer (Bergmann et al., 1999). After
6 h incubation at 37 1C, cells were harvested and directly acquired
on a FACSCalibur ﬂow cytometer (BD Biosciences). Data were
analyzed by FlowJo 7.6 software (Tree Star Inc., Ashland, OR).
Speciﬁc lysis was calculated based on the following formula: [1
(ratio of targets only/ratio of targetþT cells)]100.
Gene expression
Spinal cords were homogenized in TRIzol (Invitrogen, Carlsbad,
CA) using a TissueLyzer and stainless steel beads (Qiagen, Valencia
CA) and RNA isolated as previously described (Ireland et al., 2008).
Brieﬂy, following addition of chloroform samples were centrifuged
at 12,000g for 15 min at 4 1C. RNA was precipitated with isopropyl
alcohol, washed with 75% ethanol and resuspended in RNase-free
water (Gibco/Invitrogen, Grand Island, NY). DNA was eliminated
using a DNA-free kit (Ambion, Austin, TX) according to the
manufacturer's instructions. The cDNA was obtained by reverse
transcription using 2 mg of RNA, Moloney murine leukemia virus
reverse transcriptase (Invitrogen, Carlsbad, CA), 10 mM of deox-
ynucleoside triphosphate mix, and 250 ng of random hexamer
primers (Invitrogen, Carlsbad, CA) for 1 h at 37 1C. Real-time
quantitative PCR (qRT-PCR) used SYBRs Green in a 7500 Fast
Real-time PCR system (Applied Biosystems, Foster City, CA).
Primers speciﬁc for the JHMV N gene were: (F: forward, R: reverse)
5'-CGCAGAGTATGGCGACGAT-3' (F) and 5'-GAGGTCCTAGTC-
TCGGCCTGTT-3' (R). Ct values were normalized to GAPDH mRNA
levels using the following formula: 2[Ct (GAPDH)Ct (gene of interest)]
1000 where Ct is the threshold cycle as previously described
(Puntambekar et al., 2011).
Histopathological analysis
Spinal cordswere ﬁxed in 10% Zinc formalin, divided into 6 sections
corresponding to cervical, thoracic and lumbar regions and embedded
in parafﬁn as described previously (Hindinger et al., 2012) Sections
were stained with hematoxylin and eosin (H&E) to visualize inﬂam-
mation or Luxol Fast Blue (LFB) to visualize myelin. For viral antigen,
sections were incubated with anti-JHMV mAb J.3.3 speciﬁc for the
viral N protein and visualized using immunoperoxidase-labeled anti-
mouse mAb (Vectastain-ABC kit, Vector Laboratories, Burlingame, CA).
Sections were scored in a blind manner for inﬂammation, demyelina-
tion, and viral antigen. Stained spinal cord sections of all 6 levels on
individual slides were scanned with an Aperio ScanScope (Vista, CA) at
40 and digitally imaged at high resolution. Spinal cord sections of all
6 levels on individual slides stained with LFB were used to quantify
areas of demyelination within the white matter using Aperio software
(Hindinger et al., 2012). Representative ﬁelds were identiﬁed based on
average score of all sections in each experimental group.
Statistical analysis
Statistical signiﬁcance was determined using standard two-tailed
Student's t test, assessed by GraphPad Prism 5.0 software (La Jolla, CA).
The results are shown as either mean7SEM or mean7SD for each
group. A value of po0.05 was considered statistically signiﬁcant.
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